NOY

Product Code: NOY


Products Classified as NOY

2040Agents, Embolic, For Treatment Of Benign Prostatic HyperplasiaProstatic Artery Embolization Device.

Total Product Life Cycle (TPLC) Devices

2040Agents, Embolic, For Treatment Of Benign Prostatic HyperplasiaProstatic Artery Embolization Device.

Pre-market Notifications for NOY

K192684HydroPearl MicrospheresMicroVention, Inc.
K180102Embozene Color-Advanced MicrospheresBoston Scientific

Global Unique Device Identification Database

00884450299456Agents, embolic, for treatment of benign prostatic hyperplasia
10884450299446Agents, embolic, for treatment of benign prostatic hyperplasia
00191506011383Agents, embolic, for treatment of benign prostatic hyperplasia
00191506011345Agents, embolic, for treatment of benign prostatic hyperplasia
00810563021493Agents, embolic, for treatment of benign prostatic hyperplasia
00810563021158Agents, embolic, for treatment of benign prostatic hyperplasia
00810563021141Agents, embolic, for treatment of benign prostatic hyperplasia
00810563021127Agents, embolic, for treatment of benign prostatic hyperplasia
00810563021103Agents, embolic, for treatment of benign prostatic hyperplasia
00810563021066Agents, embolic, for treatment of benign prostatic hyperplasia

Maude Adverse Events

EMBOSPHERES MICROSPHERESMERIT MEDICAL2019-07-19
EMBOSPHERES MICROSPHERESMERIT MEDICAL SYSTEMS, INC.2019-07-11
EMBOSPHERES MICROSPHERESMERIT MEDICAL SYSTEMS, INC.2019-07-01
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.